Geneos Wealth Management’s Capital Group Growth ETF CGGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.3M Sell
554,586
-646,453
-54% -$27.9M 0.52% 39
2025
Q4
$53.4M Buy
1,201,039
+12,053
+1% +$532K 1.31% 8
2025
Q3
$52.2M Buy
1,188,986
+417,119
+54% +$17.6M 1.33% 5
2025
Q2
$31.4M Sell
771,867
-523,546
-40% -$19.1M 0.77% 16
2025
Q1
$44.9M Buy
1,295,413
+698,995
+117% +$26.2M 0.65% 26
2024
Q4
$22.2M Sell
596,418
-44,966
-7% -$1.65M 0.78% 21
2024
Q3
$22.3M Sell
641,384
-7,707
-1% -$255K 0.85% 19
2024
Q2
$21.3M Buy
649,091
+120,495
+23% +$3.82M 0.95% 17
2024
Q1
$16.9M Buy
528,596
+79,956
+18% +$2.4M 0.77% 24
2023
Q4
$12.7M Buy
448,640
+444,334
+10,319% +$11.5M 0.63% 33
2023
Q3
$105K Buy
4,306
+2,399
+126% +$60.9K 0.01% 858
2023
Q2
$48.1K Buy
+1,907
New +$44.4K ﹤0.01% 1089

Other funds holding CGGR

Geneos Wealth Management's CGGR Position: Q1 2026 in Review

Geneos Wealth Management reduced its Capital Group Growth ETF (CGGR) stake by 54% in Q1 2026, selling an estimated $27.9M and leaving 554,586 shares worth $22.3M. The position accounts for 0.52% of the portfolio, ranked #39.

Geneos Wealth Management first reported a position in CGGR in Q2 2023 and has held it in 12 quarters since. The position peaked at $53.4M in Q4 2025. 601 funds tracked by Wall St. Rank hold CGGR as of Q1 2026.

  • Geneos Wealth Management held 554,586 shares of Capital Group Growth ETF worth $22.3M as of Q1 2026.
  • Geneos Wealth Management sold 646,453 Capital Group Growth ETF shares in Q1 2026, an estimated $27.9M.
  • Capital Group Growth ETF made up 0.52% of Geneos Wealth Management's portfolio in Q1 2026, its #39 holding.
  • Geneos Wealth Management first reported a position in Capital Group Growth ETF in Q2 2023 and has held it in 12 quarters since.
  • Geneos Wealth Management's Capital Group Growth ETF position peaked at $53.4M in Q4 2025.
  • 601 funds tracked by Wall St. Rank held Capital Group Growth ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.